New data from the Phase 2 OVATION 2 study highlights potential improvements in survival outcomes with IMUNON's IMNN-001 for ...

Comprehensive Genomic Profiling (CGP) is reshaping cancer treatment by enabling precision oncology at an unprecedented scale.

Cytokine therapies have the potential to transform cancer treatment by enhancing the body’s immune response to fight cancer ...

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, especially ...

Promises of Innovation, Speed, and Savings,’ the latest research report by S&P Global Ratings. In a special session, we’ll ...

This novel DNA plasmid vaccine targets antigen-presenting cells and aims to induce a robust immune response. Prof. Lindy ...

The U.S. Food and Drug Administration (FDA) has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing (NGS)-based companion diagnostic, to identify patients eligible for ...